Ignite Creation Date:
2025-12-26 @ 11:07 AM
Ignite Modification Date:
2025-12-29 @ 4:15 AM
Study NCT ID:
NCT00004412
Status:
COMPLETED
Last Update Posted:
2015-03-31
First Post:
1999-10-18
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Randomized Trial:Arginine Butyrate Plus Standard Local Therapy in Patients With Refractory Sickle Cell Ulcers
Sponsor:
Susan P. Perrine
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
1997-09
Start Date Type:
None
Primary Completion Date:
2002-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-02
Completion Date Type:
ACTUAL
First Submit Date:
1999-10-18
First Submit QC Date:
None
Study First Post Date:
1999-10-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-07-22
Results First Submit QC Date:
None
Results First Post Date:
2015-03-31
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-03-18
Last Update Post Date:
2015-03-31
Last Update Post Date Type:
ESTIMATED